StonvexLoading…
StonvexStonvexStonvexCore line items from BDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.93B | $9.20B | $5.25B | $21.84B | $15.95B |
Operating Income | Not available | $562.00M | $552.00M | $2.58B | $1.88B |
Net Income | Not available | $72.00M | $382.00M | $1.68B | $1.19B |
EPS (Diluted) | $3.16 | $0.25 | $1.34 | $5.82 | $4.10 |
Total Assets | Not available | $50.83B | $54.84B | $55.33B | $54.90B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $813.00M | $740.00M | $567.00M | $735.00M |
Free Cash Flow OCF − CapEx | Not available | $1.09B | $549.00M | $2.67B | $1.67B |
Shares Outstanding | Not available | 284.63M | 285.85M | 288.51M | 288.69M |